Journal article
No evidence for drug resistance by iminosugar-based HCV assembly inhibitors in tissue culture
- Abstract:
-
At present, neither a selective antiviral therapy nor a vaccine is available for HCV, and the current treatment is only effective in a fraction of patients. Given the recent demonstration that antiviral compounds targeting the NS5B polymerase and the NS3/4A protease lead to rapid selection for resistance, iminosugar derivatives as HCV assembly inhibitors were characterized for drug resistance. It has been previously shown that deoxynojirimycin (DNJ)-containing iminosugars are potent HCV antiv...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Journal of Hepatology Journal website
- Volume:
- 52
- Pages:
- S261-S262
- Publication date:
- 2010-04-13
- DOI:
- ISSN:
-
0168-8278
- Source identifiers:
-
100734
Item Description
- Pubs id:
-
pubs:100734
- UUID:
-
uuid:ca51c17f-8eb1-473e-bd27-7bf46cd1b6c7
- Local pid:
- pubs:100734
- Deposit date:
- 2012-12-19
Terms of use
- Copyright holder:
- European Association for the Study of the Liver
- Copyright date:
- 2010
- Notes:
- © 2010 European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. All rights reserved.
If you are the owner of this record, you can report an update to it here: Report update to this record